Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Asset Writedowns and Impairment: 2021-2025

Historic Asset Writedowns and Impairment for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to $13,000.

  • Biofrontera's Asset Writedowns and Impairment fell 61.76% to $13,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $7,000, marking a year-over-year decrease of 90.67%. This contributed to the annual value of $162,000 for FY2024, which is 32.79% up from last year.
  • As of Q3 2025, Biofrontera's Asset Writedowns and Impairment stood at $13,000, which was up 218.18% from -$11,000 recorded in Q2 2025.
  • Biofrontera's Asset Writedowns and Impairment's 5-year high stood at $94,000 during Q3 2023, with a 5-year trough of -$46,000 in Q1 2025.
  • Its 3-year average for Asset Writedowns and Impairment is $21,818, with a median of $14,000 in 2023.
  • Examining YoY changes over the last 5 years, Biofrontera's Asset Writedowns and Impairment showed a top increase of 9,200.00% in 2022 and a maximum decrease of 1,200.00% in 2022.
  • Quarterly analysis of 5 years shows Biofrontera's Asset Writedowns and Impairment stood at $8,000 in 2021, then crashed by 162.50% to -$5,000 in 2022, then slumped by 620.00% to -$36,000 in 2023, then soared by 241.67% to $51,000 in 2024, then slumped by 61.76% to $13,000 in 2025.
  • Its last three reported values are $13,000 in Q3 2025, -$11,000 for Q2 2025, and -$46,000 during Q1 2025.